F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. 1998

W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
Centre de Recherche Pierre Fabre, Castres Cedex, France.

F 11440 (4-methyl-2-[4-(4-(pyrimidin-2-yl)-piperazino)-butyl]-2H, 4H-1,2,4-triazin-3,5-dione) was the outcome of a research effort guided by the hypothesis that the magnitude of the intrinsic activity of agonists at 5-HT1A receptors determines the magnitude of their antidepressant and anxiolytic-like effects. The affinity of F 11440 for 5-HT1A binding sites (pKi, 8.33) was higher than that of buspirone (pKi, 7.50), and somewhat lower than that of flesinoxan (pKi, 8.91). In vivo, F 11440 was 4- to 20-fold more potent than flesinoxan, and 30- to 60-fold more potent than buspirone, in exerting 5-HT1A agonist activity at pre- and postsynaptic receptors in rats (measured by, for example, its ability to decrease hippocampal extracellular serotonin (5-HT) levels and to increase plasma corticosterone levels, respectively). F 11440 did not have detectable antidopaminergic activity (unlike buspirone, which inhibited all of the directly observable behavioral effects of methylphenidate in rats), showed no evidence of antihistaminergic activity (unlike flesinoxan, which protected against the effects of a histamine aerosol in guinea pigs), and had a 70-fold separation between its 5-HT1A agonist and alpha-1 adrenergic antagonist properties (measured as the ability to inhibit the methoxamineinduced increase in blood pressure in rats), unlike flesinoxan, which showed a <3-fold separation. In HeLa cells expressing human 5-HT1A receptors, F 11440 decreased the forskolin-induced increase in AMP, and, based on its maximal effect, was found to have an intrinsic activity of 1.0 relative to that of 5-HT, which was significantly higher than that of buspirone (0.49), ipsapirone (0.46) and flesinoxan (0.93). Consistent with the aforementioned hypothesis, F 11440 produced anxiolytic- and antidepressant-like effects in animal models (i.e., increased punished responding in a pigeon conflict procedure and decreased immobility in a rat forced swimming test, respectively) that were more substantial than those of buspirone, ipsapirone and flesinoxan. Thus, F 11440, shown here to be a potent, selective, high efficacy 5-HT1A receptor agonist, appears to have the potential to exert marked anxiolytic and antidepressant activity in humans.

UI MeSH Term Description Entries
D008297 Male Males
D010856 Columbidae Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable. Columba livia,Doves,Pigeons,Domestic Pigeons,Feral Pigeons,Rock Doves,Rock Pigeons,Domestic Pigeon,Dove,Dove, Rock,Doves, Rock,Feral Pigeon,Pigeon,Pigeon, Domestic,Pigeon, Feral,Pigeon, Rock,Pigeons, Domestic,Pigeons, Feral,Pigeons, Rock,Rock Dove,Rock Pigeon
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D003220 Conflict, Psychological The internal individual struggle resulting from incompatible or opposing needs, drives, or external and internal demands. In group interactions, competitive or opposing action of incompatibles: antagonistic state or action (as of divergent ideas, interests, or persons). (from Merriam-Webster's Collegiate Dictionary, 10th ed) Conflict, Psychology,Psychological Conflict,Psychological Conflicts
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
January 1990, Progress in clinical and biological research,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
February 2022, Naunyn-Schmiedeberg's archives of pharmacology,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
January 1988, Psychopharmacology bulletin,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
March 1998, European journal of pharmacology,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
April 2010, European journal of medicinal chemistry,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
January 1994, Journal of psychopharmacology (Oxford, England),
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
June 2008, Neuropharmacology,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
December 2020, ACS chemical neuroscience,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
March 2021, Behavioural brain research,
W Koek, and J F Patoiseau, and M B Assié, and C Cosi, and M S Kleven, and E Dupont-Passelaigue, and E Carilla-Durand, and C Palmier, and J P Valentin, and G John, and P J Pauwels, and J P Tarayre, and F C Colpaert
March 1997, Journal of medicinal chemistry,
Copied contents to your clipboard!